Abstract:Reduced plasma adiponectin (APN) level not only contributes to the increased incidence of MI in diabetic patients, but also plays a causative role in increased cardiac injury after MI in these patients. However, singling mechanisms by which APN achieves its cardioprotection remains incompletely understood. Here, we investigated the role of AMP activated protein kinase (AMPK), the molecule that transfers APN’s metabolic signaling, in APN’s cardioprotection. Male adult mice with cardiac specific overexpression of a dominant negative AMPK α 2 subunit (AMPK-DN) or wild type (WT) littermates controls were subjected to 30 min of MI followed by reperfusion (R) and treated with vehicle (V) or globular domain of APN (gAPN, 2 μg/g) 10 min before R. Comparing with WT mice, MI/R caused greater cardiac injury including larger infarct size, more apoptosis and poorer cardiac function (P<0.05) in AMPK-DN mice. Treatment of WT mice with gAPN significantly attenuated MI/R injury (P<0.01). Most interestingly, although the metabolic regulatory effect of gAPN is completely lost in AMPK-DN mice, a significant portion of cardioprotection of gAPN retained in the transgenic animals. Specifically, treatment of AMPK-DN mice with gAPN reduced infarct size (54±4.7% vs. 81±3.6% in V group, P<0.01), decreased apoptosis (lesser TUNEL positive labeling, weaker DNA fragmentation, and lower caspase 3 activity. P value all <0.01) and improved cardiac function after MI/R (higher LVEF, lower LVEDP and higher dP/dt max . P value all <0.01). To further delineate the mechanisms responsible for gAPN’s AMPK-independent cardioprotection, effect of gAPN on cardiac oxidative/nitrative stress following MI/R were examined. Treatment of AMPK-DN mice with gAPN reduced superoxide and nitric oxide overproduction, decreased peroxynitrite formation (from 0.38±0.04 to 0.23±0.02 ng/mg protein in WT and from 0.50±0.06 to 0.32±0.02 ng/mg protein in AMPK-DN mice), and inhibited NADPH oxidase and iNOS expression to the same extent as that seen in WT mice. Taken together, our results demonstrated for the first time that a significant portion of gAPN cardioprotection is not mediated by the traditional AMPK signaling pathway and that the anti-oxidative/anti-nitrative effects of gAPN are AMPK-independent.

Adrenomedullin Protects Against Myocardial Apoptosis after Ischemia/Reperfusion Through Activation of Akt-GSK Signaling

Adrenomedullin Gene Delivery Protects Against Cerebral Ischemic Injury by Promoting Astrocyte Migration and Survival.

[Adenosine Protects Cardiomyocytes from Hypoxia/reoxygenation Injury].

Postischemic Infusion of Adrenomedullin Protects Against Ischemic Stroke by Inhibiting Apoptosis and Promoting Angiogenesis

The Myocardial Response to Adrenomedullin Involves Increased Camp Generation As Well As Augmented Akt Phosphorylation

Abstract 19689: Kdm3a Protects Myocardium from Ischemia/reperfusion Injury Through Targeting Akt-dependent Signaling Pathways

Protective effect of adrenomedulin (13-52) on isoproterenol-induced myocardial injury in rats

Globular Domain Of Adiponectin Attenuates Post-Ischemia Myocardial Oxidative/Nitrative Stress In An Ampk-Independent Fashion

Activation of Akt/GSK-3β Signaling Pathway is Involved in Intermedin 1–53 Protection Against Myocardial Apoptosis Induced by Ischemia/reperfusion

Cardioprotective Effect of Adiponectin is Partially Mediated by Its AMPK-independent Antinitrative Action.

Kallikrein/Kinin Protects Against Myocardial Apoptosis after Ischemia/Reperfusion Via Akt-Glycogen Synthase Kinase-3 and Akt-Bad·14-3-3 Signaling Pathways

AMELIORATION OF CARDIAC FUNCTION IN CHRONIC MYOCARDIAL INFARCTED RATS FOLLOWING ADMINISTRATION OF VECTOR Pcdna3.1am

Intramyocardial Injection of Recombinant Adeno-Associated Viral Vector Coexpressing PR39/Adrenomedullin Enhances Angiogenesis and Reduces Apoptosis in a Rat Myocardial Infarction Model

Protective Effects of PI3KCG Gene on Acute Myocardial Infarction.

Human adrenomedullin and its binding protein attenuate organ injury and reduce mortality after hepatic ischemia-reperfusion

Ad-HGF Improves the Cardiac Remodeling of Rat Following Myocardial Infarction by Upregulating Autophagy and Necroptosis and Inhibiting Apoptosis.

Vascular Endothelial Growth Factor 165 and Angiopoietin-1 Protected Myocardium Through Phosphatidy Linositol-3 Kinase and Bcl-2 Signaling Pathways

Bench-to-bedside pharmacology of adrenomedullin

Adrenomedullin in heart failure: potential therapeutic implications

Intermedin1–53 Enhances Angiogenesis and Attenuates Adverse Remodeling Following Myocardial Infarction by Activating AMP-activated Protein Kinase

Edaravone attenuates myocyte apoptosis through the JAK2/STAT3 pathway in acute myocardial infarction.